Regulation .01-1 Restricted Use of Medications and Other Substances.
Regulation .01-1 Restricted Use of Medications and Other Substances.LinkCopy Citation
The use of the following medications and other substances is permitted if quantitated at not more than the specified thresholds:
A.
Acepromazine quantitated at not more than 10 nanograms per milliliter of HEPS in urine;
B.
Albuterol quantitated at not more than 1 nanogram per milliliter of urine;
C.
Butorphanol quantitated at not more than 300 nanograms per milliliter of total butorphanol in urine, or 2 nanograms per milliliter of free butorphanol in blood plasma or serum;
D.
Caffeine quantitated at not more than 100 nanograms per milliliter of blood plasma or serum;
E.
Cetirizine quantitated at not more than 6 nanograms per milliliter of blood plasma or serum;
F.
Cimetidine quantitated at not more than 400 nanograms per milliliter of blood plasma or serum;
G.
Cobalt quantitated at not more than 25 nanograms per milliliter of blood plasma or serum;
H.
Dantrolene qunatitated at not more than 100 picrograms per milliliter of 5-hydroxydantrolene in blood plasma or serum;
I.
Detomidine quantitated at not more than 2 nanograms per milliliter of carboxydetomidine in urine, or 1 nanogram of detomidine per milliliter of blood plasma or serum;
J.
Dimethlysulfoxide (DMSO) quantitated at not more than 10 micrograms per milliliter of blood plasma or serum;
K.
Flunixin quantitated at not more than 5 nanograms per milliliter of blood plasma or serum;
L.
Furosemide (Lasix), as provided in Regulation .08 of this chapter;
M.
Gamma aminobutyric acid quantitated at not more than 110 nanograms per milliliter of blood plasma or serum;
N.
Glycopyrrolate quantitated at not more than 3 picograms per milliliter of blood plasma or serum;
O.
Guaifenesin quantitated at not more than 12 nanograms per milliliter of blood plasma or serum;
P.
Ketoprofen quantitated at not more than 2 nanograms per milliliter of blood plasma or serum;
Q.
Lidocaine quantitated at not more than 20 picograms per milliliter of total 3-hydroxylidocaine in blood plasma or serum;
R.
Mepivacaine quantitated at not more than 10 nanograms per milliliter of total hydroxymepivacaine in urine, or the limit of detection of mepivacaine in blood plasma or serum;
S.
Methocarbamol quantitated at not more than 1 nanogram per milliliter of blood plasma or serum;
T.
Methylprednisolone quantitated at not more than 100 picograms per milliliter of blood plasma or serum;
U.
Omeprazole quantitated at not more than 10 nanograms per milliliter of blood plasma or serum;
V.
Phenylbutazone quantitated at not more than 0.3 micrograms per milliliter of the blood plasma or serum;
W.
Procaine Penicillin quantitated at not more than 25 nanograms per milliliter of blood plasma or serum;
X.
Ranitidine quantitated at not more than 40 nanograms per milliliter of blood plasma or serum;
Y.
Xylazine quantitated at not more than 200 picigrams per milliliter of blood plasma or serum;
Z.
Nandrolone quantitated at not more than 1 nanogram per milliliter of urine taken from a gelding, filly, or mare;
AA.
Boldenone quantitated at not more than 15 nanograms per milliliter of urine taken from a colt or horse;
BB.
Testosterone quantitated at not more than 20 nanograms per milliliter of urine taken from a gelding; and
CC.
Testosterone quantitated at not more than 55 nanograms per milliliter of urine taken from a filly or mare.